New research reveals that people who stop using popular slimming jabs like Wegovy and Mounjaro tend to recover reduced body mass far faster than those who halt conventional diet and exercise plans.
Published data in a major health publication shows that while overweight individuals frequently drop about a fifth of their body weight while undergoing treatment, the weight comes back at an average rate of nearly a kilo each month after stopping.
"People buying these treatments must be aware of the potential of rapid rebound weight gain when the medication ends," cautioned researcher Dr. Susan Jebb.
Such speed of recovery suggests a return to starting weight within about 18 months.
Analyzing Therapies
The study, which looked at dozens of trials involving thousands of patients, compared the effects of the injectable medications with conventional dieting.
The team point out that individuals who lose weight through dieting typically experience a more gradual creep back—approximately 100 grams monthly—once they finish.
Explaining the Fast Rebound
Nutrition scientists believe the mode of action of the jabs accounts for the heightened rebound.
GLP-1 drugs mimic a body's own chemical called GLP-1, which moderates appetite.
"Long-term administration of the hormone levels far above than the body's typical production could lead to the system to produce less of its own natural GLP-1, and could reduce responsiveness to its actions," noted Dr. Adam Collins, a dietetics expert.
"Stopping of this medication results in appetite is no longer kept in check, making excessive eating much more probable."
An Ongoing Disease?
Medical guidelines advise the injections for individuals with weight-linked health risks, accompanied by recommended lifestyle changes.
Many experts say that, considering the likelihood of weight regain, the therapy should be considered life-long.
This view is echoed by drug manufacturers, who note that the findings "underscore the persistent nature of excess weight," similar to managing diseases like diabetes.
Patient Experiences
Users who have discontinued the jabs describe a powerful return of cravings.
"It felt as if a trigger activating and you're instantly extremely hungry," said one woman.
The struggle is worsened if patients have not adopted permanent lifestyle or habit modifications during treatment.
Significant Interest
Figures indicate that millions of adults in the UK have used weight-loss jabs in the last 12 months, with desire being substantial.
- Adoption is higher among females than males.
- The 40s and 50s age group shows the highest usage rates.
- A large proportion access the medications through private prescriptions rather than the NHS.
Finally, researchers stress that while GLP-1 drugs are potent agents for weight loss, they are not a standalone cure and lasting health benefits likely depends on integrated lifestyle management.